- Politics Eight midterm races putting pharma — and its influence — front and center
- Health Immunotherapy drugs show some promise against breast cancer
- Exclusive Head of IBM Watson Health leaving post after company stumbles, growing criticism
- Politics Decrying political pressure at FDA, former commissioners push a breakaway plan
- Pharma Is ‘STING’ a new and promising cancer target? Don’t look at Merck’s study results for a definitive answer
- Exclusive Head of IBM Watson Health leaving post after company stumbles, growing criticism
- In the Lab Saving Mila: How a tailor-made therapy, developed in a flash, may have halted a young girl’s rare disease
- Exclusive Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research
-
- First Opinion Flooding the world with psychiatric drugs could boost the burden of mental disorders
- First Opinion Mental health patients, with nowhere else to go, are overwhelming emergency departments
